Cargando…
Bilirubin in coronary artery disease: Cytotoxic or protective?
Bilirubin has traditionally been considered a cytotoxic waste product. However, recent studies have shown bilirubin to have anti-oxidant, anti-inflammatory, vasodilatory, anti-apoptotic and anti-proliferative functions. These properties potentially confer bilirubin a new role of protection especiall...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5095566/ https://www.ncbi.nlm.nih.gov/pubmed/27867680 http://dx.doi.org/10.4292/wjgpt.v7.i4.469 |
_version_ | 1782465304149884928 |
---|---|
author | Gupta, Nancy Singh, Tavankit Chaudhary, Rahul Garg, Sushil K Sandhu, Gurprataap Singh Mittal, Varun Gupta, Rahul Bodin, Roxana Sule, Sachin |
author_facet | Gupta, Nancy Singh, Tavankit Chaudhary, Rahul Garg, Sushil K Sandhu, Gurprataap Singh Mittal, Varun Gupta, Rahul Bodin, Roxana Sule, Sachin |
author_sort | Gupta, Nancy |
collection | PubMed |
description | Bilirubin has traditionally been considered a cytotoxic waste product. However, recent studies have shown bilirubin to have anti-oxidant, anti-inflammatory, vasodilatory, anti-apoptotic and anti-proliferative functions. These properties potentially confer bilirubin a new role of protection especially in coronary artery disease (CAD), which is a low grade inflammatory process exacerbated by oxidative stress. In fact, recent literature reports an inverse relationship between serum concentration of bilirubin and the presence of CAD. In this article, we review the current literature exploring the association between levels of bilirubin and risk of CAD. We conclude that current evidence is inconclusive regarding the protective effect of bilirubin on CAD. A causal relationship between low serum bilirubin level and increased risk of CAD is not currently established. |
format | Online Article Text |
id | pubmed-5095566 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Baishideng Publishing Group Inc |
record_format | MEDLINE/PubMed |
spelling | pubmed-50955662016-11-19 Bilirubin in coronary artery disease: Cytotoxic or protective? Gupta, Nancy Singh, Tavankit Chaudhary, Rahul Garg, Sushil K Sandhu, Gurprataap Singh Mittal, Varun Gupta, Rahul Bodin, Roxana Sule, Sachin World J Gastrointest Pharmacol Ther Review Bilirubin has traditionally been considered a cytotoxic waste product. However, recent studies have shown bilirubin to have anti-oxidant, anti-inflammatory, vasodilatory, anti-apoptotic and anti-proliferative functions. These properties potentially confer bilirubin a new role of protection especially in coronary artery disease (CAD), which is a low grade inflammatory process exacerbated by oxidative stress. In fact, recent literature reports an inverse relationship between serum concentration of bilirubin and the presence of CAD. In this article, we review the current literature exploring the association between levels of bilirubin and risk of CAD. We conclude that current evidence is inconclusive regarding the protective effect of bilirubin on CAD. A causal relationship between low serum bilirubin level and increased risk of CAD is not currently established. Baishideng Publishing Group Inc 2016-11-06 2016-11-06 /pmc/articles/PMC5095566/ /pubmed/27867680 http://dx.doi.org/10.4292/wjgpt.v7.i4.469 Text en ©The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. |
spellingShingle | Review Gupta, Nancy Singh, Tavankit Chaudhary, Rahul Garg, Sushil K Sandhu, Gurprataap Singh Mittal, Varun Gupta, Rahul Bodin, Roxana Sule, Sachin Bilirubin in coronary artery disease: Cytotoxic or protective? |
title | Bilirubin in coronary artery disease: Cytotoxic or protective? |
title_full | Bilirubin in coronary artery disease: Cytotoxic or protective? |
title_fullStr | Bilirubin in coronary artery disease: Cytotoxic or protective? |
title_full_unstemmed | Bilirubin in coronary artery disease: Cytotoxic or protective? |
title_short | Bilirubin in coronary artery disease: Cytotoxic or protective? |
title_sort | bilirubin in coronary artery disease: cytotoxic or protective? |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5095566/ https://www.ncbi.nlm.nih.gov/pubmed/27867680 http://dx.doi.org/10.4292/wjgpt.v7.i4.469 |
work_keys_str_mv | AT guptanancy bilirubinincoronaryarterydiseasecytotoxicorprotective AT singhtavankit bilirubinincoronaryarterydiseasecytotoxicorprotective AT chaudharyrahul bilirubinincoronaryarterydiseasecytotoxicorprotective AT gargsushilk bilirubinincoronaryarterydiseasecytotoxicorprotective AT sandhugurprataapsingh bilirubinincoronaryarterydiseasecytotoxicorprotective AT mittalvarun bilirubinincoronaryarterydiseasecytotoxicorprotective AT guptarahul bilirubinincoronaryarterydiseasecytotoxicorprotective AT bodinroxana bilirubinincoronaryarterydiseasecytotoxicorprotective AT sulesachin bilirubinincoronaryarterydiseasecytotoxicorprotective |